Quotient Investors’s Boston Scientific BSX Stock Holding History

Quotient Investors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-67,340	Closed	-$892K	–	249
2014 Q4	$892K	Sell	67,340 -212,641	-76%	-$2.72M	0.18%	123
2014 Q3	$3.31M	Sell	279,981 -55,681	-17%	-$701K	0.72%	44
2014 Q2	$4.29M	Buy	+335,662	New	+$4.36M	0.93%	30

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Quotient Investors's BSX Position: Q1 2015 in Review

Quotient Investors sold out of Boston Scientific (BSX) in Q1 2015, closing a stake of 67,340 shares — an estimated $892K sold.

Quotient Investors first reported a position in BSX in Q2 2014 and held it in 3 quarters. The position peaked at $4.29M in Q2 2014. 471 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

Quotient Investors reported no remaining Boston Scientific position as of Q1 2015 after selling out during the quarter.
Quotient Investors sold 67,340 Boston Scientific shares in Q1 2015, an estimated $892K.
Quotient Investors first reported a position in Boston Scientific in Q2 2014 and held it in 3 quarters.
Quotient Investors's Boston Scientific position peaked at $4.29M in Q2 2014.
471 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on Quotient Investors's 13F filing for Q1 2015, filed 10 Apr 2015.